Honasa Consumer

Timeline

1. 2016Honasa Consumer is incorporated and Mamaearth is launched as a baby care brand.Gurugram, Haryana
2. 2016Varun Alagh and Ghazal Alagh put in about Rs 25 lakh of their savings after failing to find safe products for their son.The founders have said there was no plan B
3. 2018The brand widens from baby care into skincare and haircare as demand outgrows the original category.
4. 2020The Derma Co. is launched as an actives led skincare brand, the first of the newer portfolio brands.
5. 2021Aqualogica and Ayuga join the portfolio as the company adds sun care and traditional recipes to its range.
6. 2022BBlunt, the salon and hair care brand, and Dr. Sheth's, a dermatologist founded skincare label, are brought into the group.
7. 2023The company files for a Rs 1,701.44 crore initial public offering, a mix of a fresh issue and an offer for sale.
8. 2023The issue opens on 31 October and closes on 2 November at a final price of Rs 324 per share.
9. 2023Honasa Consumer lists on the NSE and BSE on 7 November, becoming a rare direct to consumer beauty company on the Indian exchanges.
10. 2024Project Neev begins, replacing large super stockists with direct distributors so the company can see inventory and demand.
11. 2024The share price touches an all time intraday high of Rs 546.50 on 10 September.
12. 2024The distribution reset bites: in the September 2024 quarter the company reports a net loss of Rs 18.5 crore.Revenue fell to Rs 461 crore from Rs 496 crore a year earlier
13. 2024Between September and November the stock falls nearly 60 per cent from its high as investors question the transition.
14. 2025Management narrows its focus to hero categories and says it had spread itself too wide on investment.
15. 2025Reginald Men, a men's grooming brand, is acquired in December and grows quickly inside the portfolio.
16. 2026Honasa reports full year FY26 net profit of about Rs 200 crore, against about Rs 72 crore in FY25.
17. 2026The Derma Co. crosses an annualised revenue run rate of more than Rs 750 crore.
18. 2026The company holds its first Investor Day in June and sets a target of more than Rs 5,500 crore of revenue by FY31.
19. 2026Honasa declares its maiden dividend of Rs 3 per share.
20. 2026Acquisitions continue with Fang in oral care and Fluence Pharma, and nutraceuticals is named as the next area.
21. 2026In the June quarter net profit more than doubles to Rs 90.2 crore on revenue of Rs 756 crore.
22. 2026A block deal on 29 September moves 4.4 per cent of the equity at Rs 450 a share, worth Rs 643.4 crore.

What it does

Honasa Consumer Limited is an Indian beauty and personal care company headquartered in Gurugram, Haryana. It is best known as the parent of Mamaearth, and its products reach customers through its own websites, large online marketplaces, quick commerce platforms and a general trade network of distributors and retailers across the country.^[2]

The company runs what it calls a house of brands rather than a single label. Mamaearth, built on the promise of products free of disputed ingredients, is the largest and most recognised of them. Around it sit The Derma Co., a skincare brand built around active ingredients, Aqualogica, Dr. Sheth's, BBlunt, Ayuga and Staze, with newer additions in men's grooming, oral care and pharmaceuticals.^[2]

The operating model is deliberately asset light. Honasa does not own large factories. It designs products in house, contracts manufacturing to third party units, and spends its money on brand building and distribution rather than on plant and machinery. That keeps the capital requirement low and lets a product move from idea to shelf quickly, and it also means the brand, not the factory, is the real asset.^[8]

The market it sells into is large and getting larger. Consulting firm Redseer places India's beauty and personal care market at about 23 billion dollars in FY25 and expects it to reach roughly 40 billion dollars by FY30, driven by premiumisation and online penetration. Honasa's stated ambition is to take a bigger share of that pool with a portfolio of brands, and it is targeting revenue of more than Rs 5,500 crore by FY31.^[2]

Two things make the company unusual among Indian consumer businesses. The first is that it was born online and only later learned general trade, the dense distributor and retailer network that older consumer companies treat as their moat. The second is that it is publicly listed, which means its distribution experiments, its brand by brand numbers and its mistakes are all visible in quarterly filings rather than discussed privately.^[2]

History

Honasa began with a personal problem rather than a business plan. When Varun Alagh and Ghazal Alagh's first son, Agastya, developed eczema, the couple started reading labels on baby products sold in India and found nothing they were willing to use. Friends travelling abroad brought back basic lotions. In 2016 the two founded Honasa Consumer and launched Mamaearth with baby care products, putting in about Rs 25 lakh of their own savings.^[1]

Ghazal Alagh has described the early years as a grind against both logistics and social expectation. She has recalled standing in a manufacturing unit, exhausted and in milk stained clothes, being told that toxin free products were a luxury Indians would never pay for. The couple has said there was no plan B and that failure would have meant starting again from zero with a young child.^[1]

The brand grew on the back of India's e-commerce boom and then moved offline. As its scale increased it added brands rather than categories alone, bringing in The Derma Co., Aqualogica, Ayuga, BBlunt and Dr. Sheth's, some launched in house and some acquired.^[8] External investors came in as well, among them Fireside Ventures and Peak XV Partners, the firm formerly known as Sequoia India, both of which later sold part of their holdings in the listed company.^[5]

The listing was the event that changed the company's public profile. Honasa filed for an initial public offering of Rs 1,701.44 crore, made up of a fresh issue of Rs 365.05 crore and an offer for sale of Rs 1,336.39 crore by existing shareholders. Bidding ran from 31 October to 2 November 2023, the issue was priced at Rs 324 a share, and the shares began trading on the NSE and BSE on 7 November 2023. Kotak Mahindra Capital was the lead manager.^[8]

Less than a year after listing, the company ran into the hardest period of its short history. It concluded that its distribution model, built on large intermediaries known as super stockists, gave it too little visibility into where stock was actually sitting. An internal programme called Project Neev set out to replace those intermediaries with direct distributors. The change showed up immediately in the numbers and in the share price.^[2]

The recovery took roughly four quarters. By the March quarter of FY26 the company was reporting its third consecutive quarter of more than 20 per cent like for like revenue growth, and management said inventory held by direct distributors had normalised to between 25 and 30 days. In June 2026 Honasa held its first Investor Day as a listed company and laid out targets for FY31.^[2]

Founders and leadership

Honasa is unusual among listed Indian consumer companies in that it is still run by both of its founders. Varun Alagh is chairman and chief executive, and Ghazal Alagh is chief innovation officer, the role in which she has overseen product development and the company's design language.^[2]

Ghazal Alagh came to consumer products from art. She studied at the New York Academy of Art and was building a career as a painter before her first son was born and the family's search for safe baby products turned into a company. She has said her biggest early challenge was not logistics but societal judgment, with people asking why a mother of a newborn was running around factories.^[1]

She also became the company's most visible public face for a period, sitting on the panel of Shark Tank India in its fourth season, while Varun Alagh joined the show as a judge in the fifth season. Their television profile fed directly back into the Mamaearth brand, which was already the company's strongest marketing asset.^[11]

The couple speaks about the business in founder language rather than in the language of a conglomerate. Ghazal Alagh has argued that artificial intelligence has collapsed the cost of testing an idea, saying that what took Rs 25 lakh in 2016 can now be attempted for ten to fifteen thousand rupees, but she has also warned that AI should not be treated as a shortcut that skips the hard thinking.^[1]

Below the founders, Honasa runs a conventional listed company structure with a board, an investor relations function and quarterly disclosures. The company declined to participate in a detailed press profile of its strategy in 2026, leaving its filings and earnings calls as the primary account of how it is run.^[2]

The Mamaearth brand

Mamaearth is the brand that built Honasa and remains its core cash engine. It launched as a baby care label and then widened into skincare, haircare, body care, colour cosmetics and fragrances. Products built around ingredients such as onion, turmeric, ubtan and tea tree helped popularise the idea that Indian consumers could buy affordable personal care rooted in natural recipes rather than in conventional cosmetics.^[2]

That early promise has become much harder to defend. When Mamaearth launched, few digital first brands used the language of toxin free formulations and ingredient led beauty. Today those claims are everywhere, and the fastest growing part of the market has moved to products formulated around scientifically studied active ingredients such as niacinamide, retinol and hyaluronic acid.^[2]

The competitive pressure is visible in the numbers. On leading quick commerce platforms, Mamaearth's share of the face care category slipped to 2.56 per cent by June 2026 from 3.6 per cent a year earlier, according to market intelligence firm 1digitalstack. On Amazon, its own actives led brand, The Derma Co., ranked third in face care behind Cetaphil and Hindustan Unilever's Minimalist, while Mamaearth did not lead.^[2]

Management still treats the brand as the base of the company. On a recent earnings call Varun Alagh said Mamaearth grew in the mid teens and guided that it would deliver double digit compound growth over the next five years through distribution expansion and market share gains in core categories. The FY31 plan calls for Mamaearth alone to become a Rs 2,000 crore brand.^[6]

The strategy for the brand has therefore changed from adding products to sharpening the range. After the distribution reset, Varun Alagh told analysts that the company needed to make strong tweaks to its product mix, be sharper about where it invests, and narrow its focus to a few categories and go deep within the hero stock keeping units, the specific products such as face wash and sunscreen that carry the most demand.^[2]

The Derma Co. and the younger brands

The centre of gravity inside Honasa has shifted towards its younger brands, and The Derma Co. has become the clearest example. On the latest earnings call Varun Alagh described it as India's largest active skincare brand, citing Euromonitor and Nielsen data, and said it had crossed an annualised revenue run rate of more than Rs 750 crore.^[2]

The brand's rise is measurable in third party data as well. According to 1digitalstack, The Derma Co. ranked among the top three face care brands across leading quick commerce platforms in June 2026 with a 4.81 per cent share, up from 3.8 per cent a year earlier, while Mamaearth's share fell over the same period. The company has said it wants The Derma Co. to become a business of more than Rs 1,500 crore.^[2]

The rest of the portfolio is growing faster than the parent. Honasa's younger brands, which include The Derma Co., Aqualogica, Dr. Sheth's, BBlunt, Staze and Reginald Men, grew more than 40 per cent year on year in FY26, continuing to outpace the business as a whole.^[2]

Aqualogica covers sun care and light skincare, Dr. Sheth's carries a dermatologist founded positioning, BBlunt came with a salon network and a hair care range, and Ayuga draws on traditional Indian recipes. Staze, a colour cosmetics label, and Reginald Men, the men's grooming brand acquired in December 2025, extend the portfolio into categories the original business did not touch.^[2]

Honasa has said it wants at least two more brands with annual revenue of more than Rs 500 crore, and that Mamaearth and The Derma Co. together are expected to account for about 70 per cent of revenue. Investor Day disclosures also showed that 80 per cent of the company's innovation spending now goes to core categories, with the remaining 20 per cent reserved for experimental launches.^[2]

Distribution and retail

Distribution is the story that explains most of Honasa's recent financial history. The company grew as an online first business, selling through marketplaces and its own websites, where scale is cheap and a young brand can reach consumers across the country without building a physical network. Competing seriously with established consumer companies, however, required the shelves of neighbourhood pharmacies, cosmetic stores and supermarkets.^[2]

Until early 2024 the company reached those shelves through super stockists, large intermediaries standing between it and the distributors who serve retailers. Management concluded that the model gave it limited visibility into inventory movement and real demand. Project Neev replaced super stockists with direct distributors, giving Honasa greater control over execution, retailer relationships and replenishment.^[2]

The disruption was severe. In the September 2024 quarter, the second quarter of FY25, Honasa reported a net loss of Rs 18.5 crore against a profit of Rs 29.4 crore a year earlier, and revenue from operations fell to Rs 461 crore from Rs 496 crore. Management attributed the slowdown largely to a one time inventory correction as the distribution network was reset. Investors reacted sharply, and between September and November 2024 the stock fell nearly 60 per cent from its all time high.^[2]

Consultants quoted on the transition have argued that rebuilding a general trade network typically takes three to four quarters, and that it is as much about trust and relationships as about warehouses and trucks. Rebuilding it in under a year, while also running a listed company and a portfolio of seven brands, was always going to be uncomfortable.^[2]

The physical network behind the brands is deliberately light. As of mid 2023 the company's supply chain used 13 warehouses across seven districts in India, with the main warehouse at Pataudi in Haryana, supported by contract manufacturers rather than owned plants. The listing documents noted that 37 contract manufacturers were in use in the three months to June 2023, and that in house teams designed every new product.^[8]

Revenue and financials

Honasa's financial year runs to 31 March, so FY26 means the twelve months to March 2026. For that year the company reported net profit of about Rs 200 crore, a steep rise from about Rs 72 crore in FY25, and an operating margin of roughly 10 per cent. Management has said it wants that margin to reach 15 per cent within five years, helped by a better mix between e-commerce and quick commerce and by operating leverage on a distribution network that is already built.^[2]

The March 2026 quarter, the fourth of FY26, showed the recovery clearly. Revenue from operations rose 23 per cent year on year to Rs 675.09 crore, net profit jumped 178 per cent to Rs 69.44 crore, and earnings before interest, taxes, depreciation and amortisation rose 186 per cent to Rs 77.1 crore, a margin of 11.75 per cent. It was in that quarter that the company announced its maiden dividend of Rs 3 per share.^[6]

The June 2026 quarter, the first of FY27, was stronger again. Revenue rose 27 per cent to Rs 756 crore from Rs 595.2 crore a year earlier, net profit more than doubled to Rs 90.2 crore from Rs 41.3 crore, and EBITDA rose to Rs 110.1 crore with the margin expanding to 14.57 per cent from 7.68 per cent. The company described it as a record quarter.^[3]

The forward targets are the number to watch. At its Investor Day in June 2026 Honasa said it intends to more than double revenue to above Rs 5,500 crore by FY31, grow Mamaearth into a Rs 2,000 crore brand, build The Derma Co. into a business of more than Rs 1,500 crore and create at least two more brands above Rs 500 crore in annual revenue.^[4]

The share price has travelled a long way in both directions. Honasa set an all time intraday high of Rs 546.50 on 10 September 2024, then fell nearly 60 per cent over the following months as the distribution reset hurt. By June 2026 the stock was trading around Rs 420 with a market capitalisation of more than Rs 13,500 crore, close to a 52 week high of Rs 424.55, and it ended 6 July 2026 at Rs 468.55.^[6]

Shareholding and ownership

Honasa is controlled by its founders. As of the June 2026 quarter, promoter entities held 35.47 per cent of the company and public shareholders held 64.53 per cent, according to exchange data. Varun Alagh, the chief executive, holds the largest single stake within that promoter block.^[5]

The rest of the register is dominated by institutional investors who came in before the listing. Peak XV Partners Investments VI, an arm of the firm formerly known as Sequoia India, held 14.8 per cent, and Sequoia Capital Global Growth Fund III for the United States and India held 3.44 per cent. Fireside Ventures, an early backer, was another seller in the post listing block deals.^[5]

That institutional holding is steadily being reduced. On 29 September 2026, 1.4 crore shares, equal to 4.4 per cent of the outstanding equity, changed hands at an average price of Rs 450, a transaction worth Rs 643.4 crore. The sellers were reported to include Peak XV, Sequoia Capital Global Growth Fund III and Redwood Trust, and they entered a 45 day lock in on further sales afterwards.^[5]

For a company of this size the float matters. As pre listing investors sell down, the proportion of the company held by the public rises, the founders' relative control depends on a smaller promoter block, and the stock becomes more sensitive to the arrival of new sellers. The share price fell as much as 4 per cent on the day of the September 2026 block deal.^[5]

There is no separate holding company or complex structure of the kind seen in older Indian business groups. Honasa Consumer Limited is the listed entity, the brands sit within it, and the founders hold their stake directly or through promoter entities.^[5]

Acquisitions and new categories

Honasa has used acquisitions to move into categories it could not easily build. In 2022 it brought in BBlunt, the salon and hair care brand, and Dr. Sheth's, a skincare label with a dermatologist led positioning. Together with the in house launches of The Derma Co., Aqualogica and Ayuga, those purchases turned a single brand company into a house of brands.^[8]

The men's grooming entry came through Reginald Men, acquired in December 2025. It crossed an annualised revenue rate of Rs 100 crore and doubled its revenue year on year in the March quarter of FY26, making it one of the faster ramps inside the portfolio. The purchase also gave Honasa a category that sits naturally alongside its existing skincare brands rather than competing with them.^[2]

Fang, an oral care startup, extended the company into everyday hygiene, and Fluence Pharma took it towards pharmaceuticals. Nutraceuticals has been named as the next area of interest, a choice that would bring prescription led demand and a more premium consumer into the fold.^[2]

Strategy at the company now rests on a simple test. Most innovation spending goes to core categories, with a fifth reserved for experiments, and the target is to have at least two more brands above Rs 500 crore of annual revenue by FY31. That is a portfolio ambition rather than a product ambition, and it is the standard by which the acquisition record will be judged.^[2]

Not every bet is expected to work. The company has been explicit that its earlier portfolio had spread too wide, that the product mix needed sharpening and that investment had gone to places where returns were unclear. The newer purchases are smaller and more targeted than the 2022 round, and they are being asked to reach scale faster.^[2]

Employees, offices and manufacturing

Honasa is headquartered in Gurugram, Haryana, in the Delhi region, which is where the company was founded and where both of its founders live. It does not own large manufacturing plants. Instead it runs an asset light model in which products are designed and developed internally and then produced by contract manufacturers.^[8]

That model is a deliberate trade off. It keeps capital expenditure low and lets the company switch products quickly as consumer tastes change, but it also means quality control is exercised over partners rather than inside a factory the company controls. With more than thirty contract manufacturers in use at the time of listing, managing that network is itself a significant operational task.^[8]

The warehouse footprint is similarly lean and centrally managed. As of June 2023 the company worked through 13 warehouses spread across seven districts, with the largest at Pataudi in Haryana acting as the main node. That structure was designed for an online led business and has had to be rethought as general trade grew.^[8]

In the early years the founders were directly involved in manufacturing and packaging. Ghazal Alagh has described standing in manufacturing units while her first child was small, the stage at which the company was still proving to suppliers that Indian consumers would pay for the products it was making.^[1]

Headcount is not separately broken out in the company's public commentary, and the visible number in the business is the network of third party manufacturers, distributors and retailers rather than a large direct workforce. For a company of this scale that is the expected shape of an asset light consumer business.^[2]

Competition

Honasa competes with the largest consumer goods companies in India. Hindustan Unilever, Procter and Gamble and Marico are the incumbents whose shelves and advertising budgets it set out to challenge, and a beauty market crowded with rivals selling active ingredient led products has made the competition sharper than it was when Mamaearth launched.^[2]

The peer group also includes newer challengers. Wow Skin Science, a company built around apple cider vinegar and onion based products, saw its valuation fall to about 250 million dollars in early 2025 from a peak of around 400 million dollars, an illustration of how quickly a brand built around a single consumer proposition can lose momentum.^[2]

The structural problem is that most insurgent brands stall. A Bain and Company report on India's insurgent brands found that while more brands are crossing Rs 100 crore of revenue, most struggle to grow beyond the Rs 100 to 250 crore band, the stage at which companies must rethink distribution, brand building and expansion. Honasa's own plan, to build several brands past Rs 500 crore, is an attempt to escape that pattern.^[2]

Brokerages list the same risks. Analysts who rate the stock positively, including SBI Securities, warn that high competition, slower execution and delays in scaling the offline channel are the main threats to their forecasts, even as they pencil in high teens revenue growth and about 100 basis points of annual margin expansion.^[6]

On any single shelf the fight is now about ingredients rather than about promises. Consumers have become more likely to shop by ingredient than by brand, and a category that was once defined by the absence of something, such as sulfates or parabens, is now defined by the presence of something specific, which is a harder position to defend but a stronger one to hold.^[2]

Controversies and criticism

The company's most prominent public dispute involved sunscreen and advertising rather than a product itself. In April 2025, after a Lakme campaign by Hindustan Unilever suggested that some online bestseller sunscreens overstated their sun protection claims, Honasa alleged that the advertisements unfairly targeted The Derma Co. The dispute escalated into lawsuits in the Delhi and Bombay high courts before the two companies reached a settlement.^[2]

For Honasa the episode mattered beyond the courtroom. It showed how far the centre of gravity had moved inside the company, because a few years earlier Mamaearth would have been the brand at the centre of the fight, and this time the company put its science led skincare brand at the front instead.^[2]

The claim on which Mamaearth was originally built has also attracted criticism. The idea of toxin free formulations was a genuine differentiator when the brand launched, but as competitors adopted similar language the phrase became a marketing category rather than a technical one, and regulators elsewhere have scrutinised the use of such claims in cosmetics advertising.^[2]

The distribution reset produced the sharpest criticism from investors. Between September and November 2024 the stock fell nearly 60 per cent from its all time high as the September quarter swung to a loss of Rs 18.5 crore and revenue contracted. Investors questioned the pace and the execution of a change that management had described as necessary.^[2]

The sell down by pre listing investors has drawn attention as well. Large block deals, including the Rs 643.4 crore transaction in September 2026, put a regular supply of shares into the market and are read by some investors as a signal about the sellers' view of the company's valuation rather than only as portfolio management.^[5]

Reading the numbers

Three numbers frame Honasa for a reader trying to judge it. Revenue grew 27 per cent to Rs 756 crore in the June 2026 quarter, net profit more than doubled to Rs 90.2 crore, and the operating margin expanded to 14.57 per cent. The margin is the important one, because it is the clearest evidence yet that the rebuilt distribution network is producing operating leverage rather than only sales.^[3]

The full year picture is the same story told more slowly. Net profit of about Rs 200 crore in FY26 against about Rs 72 crore in FY25, on an operating margin of roughly 10 per cent, means the company has multiplied its profit without multiplying its revenue at the same rate, which is what a margin recovery looks like. The stated target is 15 per cent and that gap, not the revenue line, is where the next stage of the story sits.^[2]

Analysts disagree about how much of that is already priced in. SBI Securities has a buy rating and a target of Rs 475, Jefferies has a target of Rs 565 and sees an 18 per cent revenue compound annual growth rate between FY26 and FY29 with a near 23 per cent EBITDA growth rate, Emkay Global has a target of Rs 500, Antique Stock Broking has Rs 462 and JM Financial has Rs 420. Brokers see up to 38 per cent upside, and they also flag slower execution as the risk that would break the case.^[6]

The company is still young in the scheme of Indian consumer businesses. Founded in 2016 and listed in 2023, it has been public for a shorter time than most of its rivals have existed in their current form, and it is being asked to prove a multi brand model while still integrating a distribution change and a series of acquisitions.^[1]

The honest summary is that Honasa has fixed the problem that caused its worst year, has recovered profitability and has a credible plan to grow, but has not yet demonstrated that it can build several brands of scale at once. That is the open question on which the stock trades.^[2]

Related entries

Honasa's story is inseparable from its founders. Varun Alagh is co-founder, chairman and chief executive, and the person who ran the company through the distribution reset and the listing. Ghazal Alagh is co-founder and chief innovation officer, and the person behind much of the product and design work across the brands.^[2]

Several of the company's brands and competitors also have entries. Nykaa is the closest Indian listed peer in beauty retail and a channel through which Honasa's brands reach customers, and reading the two together shows the difference between a retailer and a brand owner in the same market.^[2]

The company's own website carries product information and investor disclosures, including annual reports and earnings material, and is the primary source for anything not covered here.^[12]